Chronic kidney disease: Novel insights from genome-wide association studies

Kidney and Blood Pressure Research

Volumn 34, Issue 4, 2011, Pages 225-234

  Böger, Carsten A ^a   Heid, Iris M ^a,b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Albuminuria; Chronic kidney disease; Diabetic nephropathy; End stage renal disease; Genome wide association study; Glomerular filtration rate; IgA nephropathy; Kidney function decline; Membranous nephropathy; Progression of chronic kidney disease

Indexed keywords

AFRICAN AMERICAN; ALBUMINURIA; ALMS1 GENE; APOL1 GENE; ATXN2 GENE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CUBN GENE; DAB2 GENE; DACH1 GENE; DIABETIC NEPHROPATHY; GCKR GENE; GENE; GENETIC ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; LASS2 GENE; MEMBRANOUS GLOMERULONEPHRITIS; MYH9 GENE; PHENOTYPE; PIP5K1B GENE; PRIORITY JOURNAL; PRKAG2 GENE; SH2B3 GENE; SHROOM3 GENE; SLC34A1 GENE; SLC7A9 GENE; STC1 GENE; TFDP2 GENE; UBE2Q2 GENE; UMOD GENE; VEGFA GENE;

ALLELES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 79959510825     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000326901     Document Type: Conference Paper

References (106)

1. Baumeister SE, Böger CA, Krämer BK, et al: Effect of chronic kidney disease and comor-bid conditions on health care costs: a 10-year observational study in a general population. Am J Nephrol 2010; 31:222-229.
2. Levey AS, Atkins R, Coresh J, et al: Chronic kidney disease as a global public health prob-lem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259. (Pubitemid 47172384)
3. Matsushita K, van der Velde M, Astor BC, et al: Association of estimated glomerular fil-tration rate and albuminuria with all-cause and cardiovascular mortality in general pop-ulation cohorts: a collaborative meta-analy-sis. Lancet 2010; 375: 2073-2081.
4. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based popu-lation. JAMA 2004; 291:844-850. (Pubitemid 38543772)
5. O'Seaghdha CM, Fox CS: Genetics of chron-ic kidney disease. Nephron Clin Pract 2011; 118:c55-c63.
6. Placha G, Canani LH, Warram JH, Krolewski AS: Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005; 12: 155-169. (Pubitemid 40488998)
7. Hildebrandt F: Genetic kidney diseases. Lancet 2010; 375: 1287-1295.
8. Patrakka J, Tryggvason K: New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 2009; 5: 463-468.
9. Tryggvason K, Patrakka J, Wartiovaara J: Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006; 354: 1387-1401.
10. Hinkes BG, Mucha B, Vlangos CN, et al: Ne-phrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007; 119:e907-e919. (Pubitemid 46556655)
11. McKnight AJ, Currie D, Maxwell AP: Unrav-elling the genetic basis of renal diseases; from single gene to multifactorial disorders. J Pathol 2010; 220: 198-216.
12. Estrella MM, Sperati CJ, Kao WH, Parekh RS: Genetic epidemiology of chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 283-291.
13. Köttgen A: Genome-wide association stud-ies in nephrology research. Am J Kidney Dis 2010; 56: 743-758.
14. Janssen B, Hohenadel D, Brinkkoetter P, et al: Carnosine as a protective factor in dia-betic nephropathy: association with a leu-cine repeat of the carnosinase gene CNDP1. Diabetes 2005; 54: 2320-2327. (Pubitemid 41134258)
15. Vardarli I, Baier LJ, Hanson RL, et al: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002; 62: 2176-2183. (Pubitemid 35366173)
16. Bowden DW, Colicigno CJ, Langefeld CD, et al: A genome scan for diabetic nephropathy in African Americans. Kidney Int 2004; 66: 1517-1526. (Pubitemid 39298385)
17. Freedman BI, Hicks PJ, Sale MM, et al: A leu-cine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant 2007; 22:1131-1135. (Pubitemid 46523428)
18. Iyengar SK, Abboud HE, Goddard KA, et al: Genome-wide scans for diabetic nephropa-thy and albuminuria in multiethnic popula-tions: the family investigation of nephropa-thy and diabetes (FIND). Diabetes 2007; 56: 1577-1585. (Pubitemid 46842614)
19. McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW: The influ-ence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Amer-icans. Hum Genet 2009; 126: 265-275.
20. Fox CS, Yang Q, Cupples LA, et al: Genome-wide linkage analysis to serum creatinine, GFR, and creatinine clearance in a commu-nity-based population: the Framingham Heart Study. J Am Soc Nephrol 2004; 15: 2457-2461. (Pubitemid 39159346)
21. Fox CS, Yang Q, Guo CY, et al: Genome-wide linkage analysis to urinary microalbumin-uria in a community-based sample: the Framingham Heart Study. Kidney Int 2005; 67:70-74. (Pubitemid 40019227)
22. Hunt SC, Coon H, Hasstedt SJ, et al: Linkage of serum creatinine and glomerular filtra-tion rate to chromosome 2 in Utah pedigrees. Am J Hypertens 2004; 17: 511-515. (Pubitemid 38726166)
23. Hunt SC, Hasstedt SJ, Coon H, et al: Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal fail-ure in the fawn-hooded rat. Kidney Int 2002; 62: 1143-1148.
24. DeWan AT, Arnett DK, Atwood LD, et al: A genome scan for renal function among hy-pertensives: the HyperGEN study. Am J Hum Genet 2001; 68: 136-144. (Pubitemid 32048368)
25. Freedman BI, Beck SR, Rich SS, et al: A ge-nome-wide scan for urinary albumin excre-tion in hypertensive families. Hypertension 2003; 42:291-296. (Pubitemid 37093475)
26. He B, Osterholm AM, Hoverfalt A, et al: Association of genetic variants at 3q22 with ne-phropathy in patients with type 1 diabetes mellitus. Am J Hum Genet 2009; 84:5-13.
27. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC: Sib-pair link-age analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998; 47: 821-830. (Pubitemid 28201814)
28. Krolewski AS, Poznik GD, Placha G, et al: A genome-wide linkage scan for genes control-ling variation in urinary albumin excretion in type II diabetes. Kidney Int 2006; 69:129-136. (Pubitemid 43117748)
29. Placha G, Poznik GD, Dunn J, et al: A ge-nome-wide linkage scan for genes control-ling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes 2006; 55:3358-3365. (Pubitemid 44923593)
30. Rogus JJ, Poznik GD, Pezzolesi MG, et al: High-density single nucleotide polymor-phism genome-wide linkage scan for suscep-tibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach. Diabetes 2008; 57: 2519-2526.
31. Turner ST, Kardia SL, Mosley TH, Rule AD, Boerwinkle E, de Andrade M: Influence of genomic loci on measures of chronic kidney disease in hypertensive sibships. J Am Soc Nephrol 2006; 17:2048-2055. (Pubitemid 44036189)
32. Osterholm AM, He B, Pitkaniemi J, et al: Ge-nome-wide scan for type 1 diabetic nephrop-athy in the Finnish population reveals sug-gestive linkage to a single locus on chromo-some 3q. Kidney Int 2007; 71: 140-145. (Pubitemid 46094687)
33. Schelling JR, Abboud HE, Nicholas SB, et al: Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic popu-lations: the Family Investigation of Ne-phropathy and Diabetes (FIND). Diabetes 2008; 57: 235-243.
34. Maeda S: Genetics of diabetic nephropathy Ther Adv Cardiovasc Dis 2008; 2:363-271.
35. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K: A comprehensive review of genetic association studies. Genet Med 2002; 4:45-61. (Pubitemid 44698579)
36. Lander ES, Linton LM, Birren B, et al: Initial sequencing and analysis of the human ge-nome. Nature 2001; 409: 860-921. (Pubitemid 32165345)
37. Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome. Science 2001; 291:1304-1351. (Pubitemid 32173090)
38. International HapMap Consortium: A hap-lotype map of the human genome. Nature 2005; 437:1299-320.
39. Marchini J, Howie B, Myers S, McVean G, Donnelly P: A new multipoint method for genome-wide association studies by imputa-tion of genotypes. Nat Genet 2007; 39: 906-913. (Pubitemid 47014502)
40. Pe'er I, Yelensky R, Altshuler D, Daly MJ: Es-timation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 2008; 32: 381-385. (Pubitemid 351656309)
41. McCarthy MI, Abecasis GR, Cardon LR, et al: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356-369. (Pubitemid 351556063)
42. Durbin RM, Abecasis GR, Altshuler DL, et al: A map of human genome variation from population-scale sequencing. Nature 2010; 467:1061-1073.
43. The 1000 Genomes Project. http://www. 1000genomes.org.
44. Klein RJ, Zeiss C, Chew EY, et al: Comple-ment factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389. (Pubitemid 40530070)
45. McPherson R, Pertsemlidis A, Kavaslar N, et al: A common allele on chromosome 9 asso-ciated with coronary heart disease. Science 2007; 316:1488-1491. (Pubitemid 46906617)
46. Helgadottir A, Thorleifsson G, Manolescu A, et al: A common variant on chromosome 9p21 affects the risk of myocardial infarc-tion. Science 2007; 316:1491-1493. (Pubitemid 46906618)
47. Samani NJ, Erdmann J, Hall AS, et al: Ge-nomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453. (Pubitemid 47204873)
48. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
49. Hindorff LA JH, Hall PN, Mehta JP, Ma-nolio TA: A catalog of published genome-wide association studies. www.genome. gov/gwastudies (accessed February 12, 2011).
50. Hindorff LA, Sethupathy P, Junkins HA, et al: Potential etiologic and functional impli-cations of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367.
51. Manolio TA, Collins FS, Cox NJ, et al: Finding the missing heritability of complex dis-eases. Nature 2009; 461:747-753.
52. Speliotes EK, Willer CJ, Berndt SI, et al: Association analyses of 249,796 individuals re-veal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948.
53. Lindgren CM, Heid IM, Randall JC, et al: Genome-wide association scan meta-analy-sis identifies three loci influencing adiposity and fat distribution. PLoS Genet 2009; 5:e1000508.
54. Heid IM, Jackson AU, Randall JC, et al: Me-ta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual di-morphism in the genetic basis of fat distribution. Nat Genet 2010; 42:949-960.
55. Willer CJ, Speliotes EK, Loos RJ, et al: Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41:25-34.
56. Kao WH, Klag MJ, Meoni LA, et al: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40:1185-1192.
57. Kopp JB, Smith MW, Nelson GW, et al: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40:1175-1184.
58. Genovese G, Friedman DJ, Ross MD, et al: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841-845.
59. Pillebout E, Burtin M, Yuan HT, et al: Prolif-eration and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal le-sions. Am J Pathol 2001; 159:547-560. (Pubitemid 32751085)
60. Schmid H, Boucherot A, Yasuda Y, et al: Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55:2993-3003. (Pubitemid 44923635)
61. Viau A, El Karoui K, Laouari D, et al: Lipo-calin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010; 120:4065-4076.
62. Bash LD, Coresh J, Kottgen A, et al: Defining incident chronic kidney disease in the re-search setting: the ARIC Study. Am J Epide-miol 2009; 170:414-424.
63. Köttgen A, Pattaro C, Böger CA, et al: New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42: 376-384.
64. National Kidney Foundation: K/DOQI clin-ical practice guidelines for chronic kidney disease: evaluation, classification, and strati-fication. Am J Kidney Dis 2002; 39:S1-S266.
65. Levey AS, Eckardt KU, Tsukamoto Y, et al: Definition and classification of chronic kid-ney disease: a position statement from Kid-ney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089-2100. (Pubitemid 41623371)
66. Lindeman RD, Tobin J, Shock NW: Longitu-dinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285. (Pubitemid 15087125)
67. Rifkin DE, Shlipak MG, Katz R, et al: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008; 168: 2212-2218.
68. Shlipak MG, Katz R, Kestenbaum B, et al: Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol 2009; 30:171-178.
69. Shlipak MG, Katz R, Kestenbaum B, et al: Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 2009; 20: 2625-2630.
70. Bash LD, Astor BC, Coresh J: Risk of incident ESRD: a comprehensive look at cardiovascu-lar risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010; 55: 31-41.
71. Hallan SI, Coresh J, Astor BC, et al: Inter-national comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17:2275-2284. (Pubitemid 44141918)
72. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and pro-gression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63:225-232. (Pubitemid 35463925)
73. Remuzzi G, Benigni A, Remuzzi A: Mecha-nisms of progression and regression of renal lesions of chronic nephropathies and diabe-tes. J Clin Invest 2006; 116:288-296. (Pubitemid 43228342)
74. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M: The early natural history of nephropathy in type 1 diabetes. 3. Predictors of 5-year urinary albumin excre-tion rate patterns in initially normoalbu-minuric patients. Diabetes 2005; 54:2164-2171. (Pubitemid 40911280)
75. Shimazaki A, Kawamura Y, Kanazawa A, et al: Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005; 54: 1171-1178. (Pubitemid 40446333)
76. Pezzolesi MG, Poznik GD, Mychaleckyj JC, et al: Genome-wide association scan for dia-betic nephropathy susceptibility genes in type 1 diabetes. Diabetes 2009; 58: 1403-1410.
77. Böger CA, Haak T, Götz AK, et al: Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study. Int J Clin Pharmacol Ther 2006; 44: 364-374. (Pubitemid 44210011)
78. Böger CA, Stubanus M, Haak T, et al: Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage dia-betic nephropathy. Nephrol Dial Transplant 2007; 22:154-162. (Pubitemid 46050340)
79. Köttgen A, Glazer NL, Dehghan A, et al: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712-717.
80. Chambers JC, Zhang W, Lord GM, et al: Ge-netic loci influencing kidney function and chronic kidney disease. Nat Genet 2010; 42: 373-375.
81. Böger C, Chen MH, Tin A, Olden M, Köttgen A, de Boer IH, et al: CUBN is a gene locus for albuminuria. J Am Soc Nephrol 2011; 22: 555-570.
82. Christensen EI, Verroust PJ, Nielsen R: Re-ceptor-mediated endocytosis in renal proxi-mal tubule. Pflugers Arch 2009; 458:1039-1048.
83. Tanaka N, Babazono T, Saito S, et al: Association of solute carrier family 12 (sodium/ chloride) member 3 with diabetic nephropa-thy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 2003; 52:2848-2853. (Pubitemid 37339716)
84. Maeda S, Kobayashi MA, Araki S, et al: A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet 2010; 6: e1000842.
85. Craig DW, Millis MP, DiStefano JK: Ge-nome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to type 1 diabetes. Diabet Med 2009; 26: 1090-1098.
86. Pezzolesi MG, Katavetin P, Kure M, et al: Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic ne-phropathy. Diabetes 2009; 58: 2698-2702.
87. Leak TS, Perlegas PS, Smith SG, et al: Vari-ants in intron 13 of the ELMO1 gene are as-sociated with diabetic nephropathy in Afri-can Americans. Ann Hum Genet 2009; 73: 152-159.
88. Hanson RL, Millis MP, Young NJ, et al: ELMO1 variants and susceptibility to dia-betic nephropathy in American Indians. Mol Genet Metab 2010; 101:383-390.
89. Hanson RL, Craig DW, Millis MP, et al: Iden-tification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes us-ing a pooling-based genome-wide single nu-cleotide polymorphism association study. Diabetes 2007; 56: 975-983. (Pubitemid 46525073)
90. Millis MP, Bowen D, Kingsley C, Watanabe RM, Wolford JK: Variants in the plasmacy-toma variant translocation gene (PVT1) are associated with end-stage renal disease at-tributed to type 1 diabetes. Diabetes 2007; 56: 3027-3032. (Pubitemid 350223639)
91. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Ep-idemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003; 290:2159-2167.
92. National Institute of Diabetes and Digestive and Kidney Disease (ed): US Renal Data Sys-tem 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Re-nal Disease in the United States. Bethesda, National Institute of Diabetes and Digestive and Kidney Disease, 2007.
93. Freedman BI, Sedor JR: Hypertension-asso-ciated kidney disease: perhaps no more. J Am Soc Nephrol 2008; 19: 2047-2051.
94. Kronenberg F: APOL1 variants and kidney disease. There is no such thing as a free lunch. Nephrol Dial Transplant 2011; 26: 775-778.
95. Bostrom MA, Freedman BI: The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol 2010; 5:1107-1113.
96. McDonough CW, Palmer ND, Hicks PJ, et al: A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 2011; 79: 563-572.
97. Freedman BI, Hicks PJ, Bostrom MA, et al: Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 2009; 24:3366-3371.
98. Feehally J, Farrall M, Boland A, et al: HLA has strongest association with IgA nephrop-athy in genome-wide analysis. J Am Soc Nephrol 2010; 21:1791-1797.
99. Gharavi AG, Kiryluk K, Choi M, et al: Ge-nome-wide association study identifies sus-ceptibility loci for IgA nephropathy. Nat Genet 2011;43:321-327.
100. Stanescu HC, Arcos-Burgos M, Medlar A, et al: Risk HLA-DQA1 and PLA(2)R1 al-leles in idiopathic membranous nephropa-thy. N Engl J Med 2011; 364:616-626.
101. Beck LH, Jr., Bonegio RG, Lambeau G, et al: M-type phospholipase A2 receptor as target antigen in idiopathic membranous ne-phropathy. N Engl J Med 2009; 361:11-21.
102. Debiec H, Guigonis V, Mougenot B, et al: Antenatal membranous glomerulonephri-tis due to anti-neutral endopeptidase anti-bodies. N Engl J Med 2002; 346: 2053-2060. (Pubitemid 34680597)
103. Prunotto M, Carnevali ML, Candiano G, et al: Autoimmunity in membranous ne-phropathy targets aldose reductase and SOD2. J Am Soc Nephrol 2010; 21:507-519.
104. Kronenberg F: Emerging risk factors and markers of chronic kidney disease progres-sion. Nat Rev Nephrol 2009; 5:677-689.
105. Köttgen A, Hwang SJ, Rampersaud E, et al: TCF7L2 variants associate with CKD pro-gression and renal function in population-based cohorts. J Am Soc Nephrol 2008; 19: 1989-1999.
106. Liu M, Shi S, Senthilnathan S, et al: Genetic variation of DKK3 may modify renal dis-ease severity in ADPKD. J Am Soc Nephrol 2010; 21:1510-1520.